Gamma Glutamyl Transferase Testing Market Opportunities, Trends, and Forecast by 2029 | Future Market Insights Report

VALLEY COTTAGE, N.Y. – Gamma glutamyl transferase testing involves the quantitative assessment of gamma glutamyl transferase. This is a membrane protein which catalyze the transfer of glutamyl to amino acids or peptides. The gamma glutamyl cycle is a pathway in which the glutathione homeostasis and detoxification of xenobiotics is carried out. The level of gamma glutamyl transferase (GGT) increases in the serum in conditions such as cardiovascular disease, liver dysfunction or disease and other metabolic syndromes. In general the gamma glutamyl transferase testing is prescribed by the doctor when liver damage or liver disease is suspected especially in case of alcohol abuse. Low appetite, vomiting or nausea, fatigue, abdominal pain, jaundice, dark urine, and itchy skin are some of the most common symptoms of liver disorders and diseases. Alcohol hepatitis is the most common liver disorder diagnosed using the gamma glutamyl transferase testing.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10578

Oxidative stress can also be asses using gamma glutamyl transferase testing. Apart from liver damage, gamma glutamyl testing can also be used to assess elevated levels of gamma glutamyl transferase due to kidney, pancreas and biliary system diseases. Alcohol abuse and abuse of certain medications also can be asses by the elevated levels of GGT through the gamma glutamyl transferase testing. However, the gamma glutamyl transferase testing is not a standalone test. The gamma glutamyl transferase testing is often followed by other blood tests such as ALT and AST that is also known as SGOT and the bilirubin test. None the less the gamma glutamyl transferase testing is a valuable testing method for uncovering many silent liver diseases that may otherwise go undiagnosed.

The alkaline phosphatase (ALP) test is generally conducted in correlation with the gamma glutamyl transferase testing. Elevated levels of both the GGT and ALP is indicative towards issues with the liver or bile. Normal level of GGT and elevated level of ALP is indicative towards a bone disease. Thus the gamma glutamyl transferase testing is also used to rule out certain diseases. Elevated levels of GGT is indicative towards alcohol abulse, hepatitis, improper blood flow to liver, liver cancer, liver cirrhosis, drug abuse or drug related liver toxicity, heart failure, diabetes, pancreatitis and fatty liver disease.

Preview Analysis of Gamma Glutamyl Transferase Testing Market – Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029: https://www.futuremarketinsights.com/reports/gamma-glutamyl-transferase-testing-market

Gamma Glutamyl Transferase Testing Market: Drivers and Restraints

Rising prevalence of cardiovascular diseases, liver disorders and diseases as well as rise in alcohol consumption globally are some of the factors that drive the growth of the gamma glutamyl transferase testing market. However, availability of alternative testing methods could hinder the growth of the gamma glutamyl transferase testing market. Furthermore, need for secondary and confirmatory testing may impact the growth of the gamma glutamyl transferase testing market negatively.

Gamma Glutamyl Transferase testing Market: Overview

The colorimetric type of gamma glutamyl transferase testing kits are most commonly used kits. This is primarily due to the lower cost when compared to the ELISA based test kit. Assay kits are easy to use, they are convenient, simple and require no or little time for optimization. The gamma glutamyl transferase is generally conducted as a blood test and is highly accurate and sensitive to alcohol, medication and smoking. Treatment for elevated levels of GGT involves lifestyle changes, change in diet and medication. The gamma glutamyl transferase testing is not a standalone test however is a highly accurate and sensitive test that can also be used for ruling out certain disease. The gamma glutamyl transferase testing can also be used for tissue lysates and cell lysates for research and diagnostic purposes.

Gamma Glutamyl Transferase testing Market: Regional Outlook

Rising obesity, diabetes and alcohol abuse in North America and Europe are the primary factors that drive the growth of the gamma glutamyl transferase testing market in the regions. North America is expected to hold the maximum share the market followed by Europe.

Buy this report @ https://www.futuremarketinsights.com/checkout/10578

However, rising incidence of diabetes in Asia Pacific and significant rise in population in the regions is driving the growth of the patient pool. This allows Asia Pacific market for gamma glutamyl transferase testing market to grow at a significantly high rate.

Gamma Glutamyl Transferase testing Market: Key Players

Some of the key players in the gamma glutamyl transferase testing market include, Merck KGaA, BioVision Inc., Creative BioMart, PromoCell, Abnova Corporation, XpressBio, Abbkine, Inc., MyBioSource, among others.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you:  https://www.futuremarketinsights.com/askus/rep-gb-10578

More from Healthcare, Pharmaceuticals and Medical devices:

• Seizure Detection Devices Market
• Ion Mobility Spectrometry Market
• Electrophoresis Transilluminator Market

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us
Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44-(0)-20-7692-8790 
Sales: sales@futuremarketinsights.com  
Press Office: Press@futuremarketinsights.com  
Blog: Market Research Blog  
Website: https://www.futuremarketinsights.com/